MD Anderson launches new institute for advancing cell therapy

The University of Texas MD Anderson Cancer Center today announced the launch of its Institute for Cell Therapy Discovery & Innovation, which will build upon longstanding MD Anderson clinical and research expertise to lead the world in developing and advancing impactful cell therapies for patients in need.

Strategic agreement signed for distribution of Yimmugo® in the United States based on the framework established in July – Biotech Investments

EQS-News: Biotest AG / Key word(s): Market Launch Strategic agreement signed for distribution of Yimmugo® in the United States based on the framework established in

October 3, 2024

Bristol immunotherapy improves responses in lung cancer, setting up Phase 3 study

BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and chemotherapy improved responses for certain patients with a

September 14, 2024

SyntheticGestalt, Enamine to develop AI drug discovery models

Share this article SyntheticGestalt will create a pre-trained artificial intelligence (AI) model to develop synthesisable drug-like candidates. Credit: metamorworks/Shutterstock.com. SyntheticGestalt and Enamine have announced a

January 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.